Log has written
TUESDAY, FEBRUARY 14, 2012

New Delhi: FMCG major Emami on Friday said that it has got the Kolkata High Court’s approval for merging the operations of Mumbai-based Zandu Pharmaceuticals with it.

The Kolkata-based Emami, which had acquired Zandu Pharmaceuticals last year for around Rs700 crore, said that the high court has approved the company’s scheme of arrangement on 17 November, with effect from 2 December.

“The high court of Kolkata has approved the scheme of arrangement of de-merger / merger of businesses between Emami Ltd, Zandu Pharmaceutical Works Ltd and Emami Infrastructure Ltd,” the company said in a statement.

Under the arrangement, the FMCG business of Zandu comprising all brands and corresponding assets and liabilities would be demerged into Emami Ltd while the realty undertaking of Emami and Zandu’s non-core business, including realty, are demerged into Emami Infrastructure Ltd.

Emami had bought 68.9% stake in Zandu Pharmaceutical and took management control of the latter.

“The acquisition was aimed at achieving synergetic benefits and to leverage on mutual strengths,” it added.

Emami sells personal care brands like Fair and Handsome, Navratna Oil, Boroplus Antiseptic Cream while from the Zandu portfolio, it has Zandu Balm, Menthoplus Balm among others.

READ MORE ARTICLES BY:
blog comments powered by Disqus
Tata Motors Q3 net up 41% on strong JLR sales
Net profit Rs3,406 crore vs market forecast Rs2,613 crore; revenue rises 44% to Rs45,260 crore; shares...
Views | Recession signals on the high seas?
The crash in shipping rates is no longer a good indicator of an incipient downturn
Views | India’s fiscal headache
India cannot bank infinitely upon growth for fiscal deliverance
Views | Still mired in caste politics
Caste politics has become even more important in recent decades, especially after the collapse of mass...
Moody’s warns may cut AAA-rating for UK and France
Germany, EFSF triple-A rating unchanged; UK top-tier rating at risk by a major agency for first time;...